For years, doctors have used cholesterol as the main measure of a person's heart health, but a new study suggests that testing for another substance in the blood may be just as important.
Aggressively lowering cholesterol as well as a substance in the blood known as C-reactive protein, or CRP, led to a greater reduction in heart attacks, strokes and deaths than cutting cholesterol alone, according to research presented at a cardiology meeting Sunday and published on the Web site of the medical journal The Lancet.
The study is the latest evidence suggesting that CRP testing should be done in large numbers of middle-aged people who normally would not be considered at risk for cardiovascular disease because their cholesterol levels are acceptable. It follows landmark research in November showing heart attacks and strokes were reduced in people with healthy cholesterol levels who substantially reduced levels of CRP in their blood by taking the cholesterol drug Crestor, one of the most potent statin drugs on the market.